Our trustees include parents of children who had leukaemia, or experts in very high risk leukaemia working in leading positions across industry
They each bring a unique perspective to this urgent issue, but share their ambition and passion for change
The Scientific Advisory Board (SAB) of the Kaiya Foundation consist of the world leading scientific and clinical experts in VHR leukemia. Beyond their unrivaled track record in VHR leukaemia, the foundation considered their scientific focus, geographical location, and involvement in relevant clinical consortia. Furthermore, their ambition in driving relevant change and cutting-edge innovation in the field that aligns with the Foundation’s vision was assessed.
The five appointed SAB members, all active physician-scientists from renown institutions, represent the arguably strongest and most focused expert panel for VHR leukaemia. Together, they cover all significant ongoing pre-clinical and clinical VHR leukemia efforts, and are involved in all relevant discussions and new projects across the US and Europe.
